Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 476 results for "zydus cadila"

Zydus Cadila gets USFDA nod for anti-hypertension drug
Business Standard

Cadila Healthcar - Zydus receives final approval for Telmisa...

The page you are looking for might have been removed, had its name changed, or is temporarily unavailable. Please try the following: Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted ... SBICAP Securities, 18 hours ago
Zydus gets USFDA nod for anti-hypertensive drug Hindu Business Line, 1 day ago
[x]  

8 images for zydus cadila

Livemint.com, 1 week ago
NDTV Profit, 3 weeks ago
Livemint.com, 3 weeks ago
Money Control, 3 weeks ago
Business Standard, 1 day ago
FDA News, 3 weeks ago
Bio Spectrum Asia, 1 month ago
NDTV Profit, 3 weeks ago

Cadila Healthcare in the pink of health

after the company said that the Zydus Group will be presenting data on its molecule ZYDPLA1, a novel compound in the Gliptin class of anti-diabetic agents. The announcement was made during market hours today, 9 June 2014. Meanwhile, the S&P BSE Sensex was up ...
 Business Standard2 months ago Buy Cadila Healthcare; target of Rs 1205: Motilal Oswal  Moneycontrol.com4 weeks ago Sensex consolidates; pharma surges; FMCG autos decline  Moneycontrol.com1 week ago

Cadila Healthcare jumps after USFDA OK for anti-viral drug

Cadila Healthcare rose 3.67% to Rs 1,235.70 at 12:50 IST on BSE after the company said Zydus Cadila has received the final approval from the US drug regulator to sell anti-viral drug in multiple strengths in the US market. The company made the ...
 Capital Market1 week ago
EGov Online

Pankaj Patel passes on baton to son at Zydus Wellness

Pankaj Patel will continue to remain the chairman and managing director of Cadila Healthcare of which Zydus Wellness is a subsidiary
 Business Standard1 month ago Patel appointed Chairman, Zydus Wellness Ltd  EGov Online1 month ago Pankaj Patel passes on reigns to son at Zydus Wellness  Business Standard1 month ago

USFDA PRODUCT-RELATED REVIEW: ZYDUS SAYS NO BUSINESS IMPACT

Zydus Cadila Ltd is of the view that the product-related observations of the US Food and Drug Administration (FDA) have no impact on its business. The company has responded to the observations on abbreviated new drug application.
 Pharmacy Choice3 weeks ago
Times of India

Zydus Cadila loses two popular brands

MUMBAI: Two popular consumer healthcare brands in the domestic market are changing hands. Around 10 years after Ahmedabad-based Zydus Cadila started manufacturing and distributing Dulcolax and Buscopan, these gastro medicines have now been ...
 Economic Times2 months ago Zydus loses 2 popular brands  Times of India2 months ago

Drug price reduction to impact Sanofi, Zydus Cadila, Ranbaxy most: Experts

Drug price reduction to impact Sanofi, Zydus Cadila, Ranbaxy most: Experts Source: IRIS (14-JUL-14) In a rare invocation of a lesser-used provision in the Drug Price Control Order (DPCO), NPPA has fixed the prices of 108 formulation packs of 50 anti-diabetic ...
 Myiris1 month ago

Drug Recall Attorney Jeffrey D. DeCarlo Comments on Voluntary Recall of 10,000 Allergy-Relief Medication Bottles

Attorney Jeffrey D. DeCarlo, P.A. weighs in on overseas drug manufacturer Zydus Cadila's seventh product recall of 2014, which occurred after a blood pressure-lowering medication was found mixed in with allergy medication. DeCarlo Law, a law firm ...
 PRWeb2 months ago
[x]  

"Zydus Cadila Healthcare Limited - Product Pipeline Review - 2014" Published

Boston, MA -- (SBWIRE) -- 08/28/2014 -- Zydus Cadila Healthcare Limited - Product Pipeline Review
 SearchBug2 days ago Zydus Cadila Healthcare Limited - Product Pipeline Review - 2014  MarketResearch.com3 weeks ago Biocon : Market Report, "Biocon Limited - Product Pipeline Review - 2014", published  4 Traders3 days ago
[x]  

Report of Form 483 for Cadila wreaks havoc with its shares

FDA report was tied to new, unreleased product, not ongoing work, company explains Share Tools Cadila's Moraiya dosage plant--Courtesy of Cadila Healthcare Given the publicity that has come with FDA bans on a growing list of Indian ...
 FiercePharmaManufacturing4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less